Bristol-Myers Squibb Co (BMY)
55.45
+1.13
(+2.08%)
USD |
NYSE |
Nov 04, 16:00
55.44
-0.01
(-0.02%)
Pre-Market: 06:40
Bristol-Myers Squibb Cash from Financing (Quarterly): -3.852B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.852B |
| June 30, 2024 | -4.023B |
| March 31, 2024 | 14.64B |
| December 31, 2023 | 967.00M |
| September 30, 2023 | -5.16B |
| June 30, 2023 | -2.173B |
| March 31, 2023 | -3.05B |
| December 31, 2022 | -3.246B |
| September 30, 2022 | -4.543B |
| June 30, 2022 | -3.52B |
| March 31, 2022 | -5.653B |
| December 31, 2021 | -3.967B |
| September 30, 2021 | -1.78B |
| June 30, 2021 | -3.182B |
| March 31, 2021 | -7.295B |
| December 31, 2020 | 3.483B |
| September 30, 2020 | -2.587B |
| June 30, 2020 | -993.00M |
| March 31, 2020 | -1.054B |
| December 31, 2019 | -7.677B |
| September 30, 2019 | -941.00M |
| June 30, 2019 | 18.27B |
| March 31, 2019 | -2.029B |
| December 31, 2018 | -578.00M |
| September 30, 2018 | -720.00M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.015B |
| March 31, 2018 | -1.222B |
| December 31, 2017 | -1.352B |
| September 30, 2017 | -706.00M |
| June 30, 2017 | -1.006B |
| March 31, 2017 | -1.013B |
| December 31, 2016 | -605.00M |
| September 30, 2016 | -546.00M |
| June 30, 2016 | -552.00M |
| March 31, 2016 | -950.00M |
| December 31, 2015 | -1.359B |
| September 30, 2015 | -700.00M |
| June 30, 2015 | -883.00M |
| March 31, 2015 | -682.00M |
| December 31, 2014 | -231.00M |
| September 30, 2014 | -528.00M |
| June 30, 2014 | -486.00M |
| March 31, 2014 | -1.192B |
| December 31, 2013 | 711.00M |
| September 30, 2013 | -620.00M |
| June 30, 2013 | -1.115B |
| March 31, 2013 | -44.00M |
| December 31, 2012 | -958.00M |
| September 30, 2012 | -1.689B |
| June 30, 2012 | -850.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-7.677B
Minimum
Dec 2019
14.64B
Maximum
Mar 2024
-2.233B
Average
-3.214B
Median
Cash from Financing (Quarterly) Benchmarks
| Amgen Inc | -3.651B |
| Johnson & Johnson | -9.882B |
| Eli Lilly and Co | 211.30M |
| Merck & Co Inc | 1.216B |
| Pfizer Inc | -2.459B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.591B |
| Cash from Investing (Quarterly) | -219.00M |
| Free Cash Flow | 13.80B |
| Free Cash Flow Per Share (Quarterly) | 2.593 |
| Free Cash Flow to Equity (Quarterly) | 7.904B |
| Free Cash Flow to Firm (Quarterly) | 5.633B |
| Free Cash Flow Yield | 12.27% |